Literature DB >> 24830723

Cyclin D1 integrates estrogen-mediated DNA damage repair signaling.

Zhiping Li1, Ke Chen1, Xuanmao Jiao1, Chenguang Wang1, Nicole E Willmarth1, Mathew C Casimiro1, Weihua Li1, Xiaoming Ju1, Sung Hoon Kim2, Michael P Lisanti3, John A Katzenellenbogen2, Richard G Pestell4.   

Abstract

The cyclin D1 gene encodes the regulatory subunit of a holoenyzme that phosphorylates the retinoblastoma protein (pRb) and nuclear respiratory factor (NRF1) proteins. The abundance of cyclin D1 determines estrogen-dependent gene expression in the mammary gland of mice. Using estradiol (E2) and an E2-dendrimer conjugate that is excluded from the nucleus, we demonstrate that E2 delays the DNA damage response (DDR) via an extranuclear mechanism. The E2-induced DDR required extranuclear cyclin D1, which bound ERα at the cytoplasmic membrane and augmented AKT phosphorylation (Ser473) and γH2AX foci formation. In the nucleus, E2 inhibited, whereas cyclin D1 enhanced homology-directed DNA repair. Cyclin D1 was recruited to γH2AX foci by E2 and induced Rad51 expression. Cyclin D1 governs an essential role in the E2-dependent DNA damage response via a novel extranuclear function. The dissociable cytoplasmic function to delay the E2-mediated DDR together with the nuclear enhancement of DNA repair uncovers a novel extranuclear function of cyclin D1 that may contribute to the role of E2 in breast tumorigenesis. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24830723      PMCID: PMC4102655          DOI: 10.1158/0008-5472.CAN-13-3137

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

2.  Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.

Authors:  Mahnaz Razandi; Gordon Alton; Ali Pedram; Sanjiv Ghonshani; Paul Webb; Ellis R Levin
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

3.  Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.

Authors:  R J Lee; C Albanese; M Fu; M D'Amico; B Lin; G Watanabe; G K Haines; P M Siegel; M C Hung; Y Yarden; J M Horowitz; W J Muller; R G Pestell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

5.  Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.

Authors:  C Albanese; M D'Amico; A T Reutens; M Fu; G Watanabe; R J Lee; R N Kitsis; B Henglein; M Avantaggiati; K Somasundaram; B Thimmapaya; R G Pestell
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

6.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

7.  Specific protection against breast cancers by cyclin D1 ablation.

Authors:  Q Yu; Y Geng; P Sicinski
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

Review 8.  Is estradiol a genotoxic mutagenic carcinogen?

Authors:  J G Liehr
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

9.  The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.

Authors:  N C Denko; A J Giaccia; J R Stringer; P J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

Authors:  Ranjit S Bindra; Paul J Schaffer; Alice Meng; Jennifer Woo; Kårstein Måseide; Matt E Roth; Paul Lizardi; David W Hedley; Robert G Bristow; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more
  19 in total

1.  Ligand Accessibility and Bioactivity of a Hormone-Dendrimer Conjugate Depend on pH and pH History.

Authors:  Sung Hoon Kim; Zeynep Madak-Erdogan; Sung Chul Bae; Kathryn E Carlson; Christopher G Mayne; Steve Granick; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  J Am Chem Soc       Date:  2015-08-10       Impact factor: 15.419

2.  Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation.

Authors:  C Chalermrujinanant; W Michowski; G Sittithumcharee; F Esashi; S Jirawatnotai
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

3.  Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.

Authors:  Huafang Su; Xiance Jin; Lanxiao Shen; Ya Fang; Zhenghua Fei; Xuebang Zhang; Congying Xie; Xiaolei Chen
Journal:  Tumour Biol       Date:  2015-11-11

Review 4.  The double dealing of cyclin D1.

Authors:  Guergana Tchakarska; Brigitte Sola
Journal:  Cell Cycle       Date:  2019-12-29       Impact factor: 4.534

5.  DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.

Authors:  Xin Sun; Shou-Ching Tang; Chongwen Xu; Chenguang Wang; Sida Qin; Ning Du; Jian Liu; Yiwen Zhang; Xiang Li; Gang Luo; Jie Zhou; Fei Xu; Hong Ren
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

6.  Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.

Authors:  Francesco Marampon; Giovanni Gravina; Xiaoming Ju; Antonella Vetuschi; Roberta Sferra; Mathew C Casimiro; Simona Pompili; Claudio Festuccia; Alessandro Colapietro; Eugenio Gaudio; Ernesto Di Cesare; Vincenzo Tombolini; Richard G Pestell
Journal:  Oncotarget       Date:  2016-02-02

7.  Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer.

Authors:  Noel P Fusté; Esmeralda Castelblanco; Isidre Felip; Maria Santacana; Rita Fernández-Hernández; Sònia Gatius; Neus Pedraza; Judit Pallarés; Tània Cemeli; Joan Valls; Marc Tarres; Francisco Ferrezuelo; Xavier Dolcet; Xavier Matias-Guiu; Eloi Garí
Journal:  Oncotarget       Date:  2016-05-10

Review 8.  Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.

Authors:  Gabriele Di Sante; Agnese Di Rocco; Claudia Pupo; Mathew C Casimiro; Richard G Pestell
Journal:  Oncotarget       Date:  2017-07-20

9.  DNA damage signaling guards against perturbation of cyclin D1 expression triggered by low-dose long-term fractionated radiation.

Authors:  T Shimura; J Kobayashi; K Komatsu; N Kunugita
Journal:  Oncogenesis       Date:  2014-12-08       Impact factor: 7.485

10.  Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin.

Authors:  Noel P Fusté; Rita Fernández-Hernández; Tània Cemeli; Cristina Mirantes; Neus Pedraza; Marta Rafel; Jordi Torres-Rosell; Neus Colomina; Francisco Ferrezuelo; Xavier Dolcet; Eloi Garí
Journal:  Nat Commun       Date:  2016-05-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.